Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda.

ABSTRACT:

Introduction

Long-acting injectable antiretroviral treatment (LAI-ART) has emerged as a novel alternative to the burden of daily oral pills. The bi-monthly intramuscular injectable containing cabotegravir and rilpivirine holds the promise of improving adherence to ART. The perspectives of potential users of LAI-ART, the majority of whom reside in Eastern and Southern Africa, are still largely unexplored. We set out to understand the experiences of people with HIV (PWH) who received LAI-ART at Fort Portal Regional Referral Hospital in mid-Western Uganda for at least 12 months.

Methods

This qualitative study, conducted between July and August 2023, was nested within a larger study. We conducted four focus groups with 32 (out of 69) PWH who received intramuscular injections of

SUBMITTER: Zakumumpa H 

PROVIDER: S-EPMC11360315 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature